Skip to main content

Oral Presentations

This year, there are two sections for the Oral Presentations: PowerPoint Presentations and Poster Presentations. Both the PowerPoint and the Poster Presentations will have the following categories: Fundamental Sciences, Clinical Sciences and Surgical Sciences.

You may submit a maximum of 4 abstracts but if more than one of your abstracts are accepted, please note that you will be contacted by our team to select which one of them will be presented, given that you can not present more than one abstract, regardless if they:

  •  are in different contests (Poster versus PowerPoint Presentations)
  • are in different sections (Fundamental/Clinical/Surgical Sciences)
  • are in different categories (Review/Original Study/Case Report).

You’ll receive notification about the acceptance of your abstract on 1st November 2024, before the registration period ends.

All Poster Presentations will be held exclusively on-site on Friday, the 6th of December 2024. The PowerPoint Presentations will be held exclusively on-site on Saturday, the 7th of December 2024. The exact schedule and location information will be shared with the participants before the 18th of November. When submitting the abstract, every On-site Presenter gives their consent to have their name mentioned in the final ranking of the scientific papers. All participants will be able to attend the presentation of the abstracts and they will also have the right to ask questions to the On-Site Presenter. However, these are not mandatory events and cannot be booked by following the standard booking procedure. One can attend by simply coming to the auditorium at the mentioned presentation date and time. On-site places will be limited in accordance with the room capacity, health regulations and administrative decisions.

In advance, every participant that has been accepted for the Oral Presentations will have to send their visual support (.ppt/.pptx for the PowerPoint presentations or the electronic format of the Poster for the Poster Presentations) until the 25th of November 2024, 23:59 GMT+2 (Romanian time zone) at the e-mail address: abstracts@imscbucharest.com

The full time schedule will be available for the participants before the 18th of November 2024.

During Oral Presentations’ day, the order in which the sections will be presented during the PowerPoint presentations is the following: 

  • Review
  • Original Study
  • Case Report

For each of the sections, the alphabetical order will be respected.  

The presentation time for each participant will be 7 minutes for PowerPoint presentations and 5 minutes for Poster Presentations, followed by a 3 minutes Q&A session (both the professors of the Scientific Committee and the other On-site Presenters will be allowed to ask questions). You will be notified during the presentation when there are 3 minutes and respectively 1 minute left of the presentation time. Please note that exceeding the time limit will influence your final score! 

In case of exceeding the time limit with more than 2 minutes, the presentation will have to be ceased by a member of the Organising Committee.

Every On-site Presenter will receive via the email address used for the registration process all the information regarding the Oral Presentations. 

On-site Presenters’ Duties: 

The On-site Presenters must be present 15 minutes before the start of the Oral Presentations competition. 

The On-site Presenters cannot leave the room before the end of the last presentation from their section (Review, Original Study, Case Report); otherwise, they will be disqualified.

The Organising Committee of the IMSCB is not responsible if any of the conditions specified above is not met. 

Evaluation of the presentations

Beforehand, the participants will receive guidelines regarding the evaluation criteria. The grading process of the presentations will be performed in real time using the Google Form platform. To eradicate bias, every participant will be evaluated considering the same criteria and the results will be sent via email within 24 hours after the last presentation. 

Awards

This year, there are two categories for the Oral Presentations: PowerPoint Presentations and Poster Presentations. Both the PowerPoint and the Poster Presentations will have the following sections: Fundamental Sciences, Clinical Sciences and Surgical Sciences. 

You may submit a maximum of 4 abstracts, but if more than one of your abstracts are accepted, please note that you will be contacted by our team to select which one of them will be presented, given that you can not present more than one abstract, regardless if they:

  •  are in different contests (Poster versus PowerPoint Presentations)
  • are in different sections (Fundamental/Clinical/Surgical Sciences)
  • are in different categories (Review/Original Study/Case Report).

You’ll receive notification about the acceptance of your abstract on 1st November 2024, before the registration period ends.

The method used to determine the award recipients consists of an average between the grade obtained for the submitted abstract and the grade for the presentation (Oral Presentation). The participants will receive their grade and the reasoning behind it within 24 hours after the last presentation. The awards for the Oral Presentations will be given as such:

PowerPoint presentations:

Three awards for each category  (3 awards for Fundamental Sciences, 3 awards for Clinical Sciences and 3 awards for Surgical Sciences).

Poster Presentations: 

Three awards, for each category (3 awards for Fundamental Sciences, 3 awards for Clinical Sciences and 3 awards for Surgical Sciences).

The awards for the PowerPoint Presentations will be selected by special Evaluation Committees, for each Category (Fundamental Sciences, Clinical Sciences, Surgical Sciences). The Evaluation Committees will consist of an equal number of specialists from various medical fields, in order to make the evaluation process equitable for all three Categories (Fundamental Sciences, Clinical Sciences, Surgical Sciences).

The awards for the Poster Presentations will be selected by an Evaluation Committee with specialists from each Category (Fundamental Sciences, Clinical Sciences, Surgical Sciences).

Be brave! Let the whole scientific world acknowledge your findings with the help of an astounding abstract. Here’s what you must know before registering as an On-Site Presenter Presenter. 

Abstract Guidelines

This year, there are two categories for the Oral Presentations: PowerPoint presentations and Poster presentations. Both the PowerPoint and the Poster presentations will have the following sections: Fundamental Sciences, Clinical Sciences and Surgical Sciences. 

If you have more than one abstract accepted, please note that you will be contacted by our team to select which of them will be presented, given that you can not present:

  • in both the PowerPoint and Poster Presentations
  • in multiple categories (Fundamental Sciences, Clinical Sciences, Surgical Science)
  • more than one abstract in the same section (Review, Original Study, Case Report).

Both, the abstract and the oral presentation (PowerPoint or Poster), must be in English. The maximum number of words in an abstract is 350, without taking into consideration the following fields: Title, Author, Co-authors, Scientific Coordinators, Affiliation and Keywords. 

The Title should not be longer than 12 words. Be creative and contain all the incredible ideas presented in the abstract in an attractive manner that will encourage everyone to read your valuable work. 

Who is submitting the abstract?

Each paper can have a maximum of 1 author, 2 co-authors and 1 scientific coordinators. The abstract is only going to be submitted by the author, who will also be presenting author and On-Site Presenter/Premium Presenter. In order to submit an abstract, the author needs an On-Site Presenter membership. All co-authors need to have their details submitted with the abstract, otherwise their registration will not be valid.

A presenting author can submit a MAXIMUM of 4 abstracts. All the submitted abstracts have to tackle different subjects. In case the participant submits more than one abstract in different categories, and all of them are eligible to be presented, he/she will be asked to choose which abstract is going to be presented. If the participants submit more drafts of the same abstract, only the last version sent before the deadline will be taken into consideration. After the deadline, the submitted abstract cannot suffer any further adjustments. 

If you encounter any problems, please contact us via the following e-mail at abstracts@imscbucharest.com.

Structure of Abstracts

Categories of Abstracts 

After registering as an On-Site Presenter/Premium Presenter (former Active Participant) and paying the fee, you should submit your abstract until the 13th of October. Depending on your major fields of interest, we have carefully designed a variety of sections of abstracts, each of them having unique features. This year, there are two categories for the Oral Presentations: PowerPoint Presentations and Poster Presentations. Both the PowerPoint and the Poster Presentations will have the following sections:

  • Fundamental Sciences  
  • Clinical Sciences  
  • Surgical Sciences 

The abstracts, regardless of their subject, have to fit in one of the following sections: 

  • Original Study 
  • Case Report 
  • Review 

Original Study

An Original Study is represented by a detailed account of research activity and it is considered a primary resource. The objective of the presentation is the expansion of knowledge and understanding in the studied phenomenon.

If requested, the participant must provide the raw data file used for statistical analysis and the complete list of references if applicable.

  • Background: It stands as a hypothesis for your study. It is a brief description of what is known about the subject you chose and its significance for your research. 
  • Materials and Methods: Relevant details about how the study was conducted, how the data was processed and how it might vary; specify the number of subjects and the steps taken in order to execute your research. 
  • Results: Present the main outcome of your original study in an attractive manner. Create a strong link between the original hypothesis and the final results, relating all of the ultimate data to it. 
  • Conclusion: This section allows you to summarise the topic and make an objective comparison with the updated specialty literature. You can also add a powerful statement that comprehends the entire idea of the Original Study, allowing new perspectives over your abstract. 

KEYWORDS are mandatory as they allow you to highlight the most important aspects of your abstract. They are a tool to help indexers and search engines find relevant papers. They should be representative but also specific for your paper.

Case report

A Case Report is a study keen on the observation of one or more patients with particular aspects of an engaging pathology. The objective of the presentation is to declare the qualities of an interesting case, to recon and to come up with useful information for your fellow colleagues. The presentation should have a short introduction that should highlight the significance of the chosen pathology, the case description, including the patient data, symptoms and diagnosis, treatment plans and conclusions.

If requested, the participant must provide the raw data file used for statistical analysis and the complete list of references if applicable.

Patient’s files are the key-materials when writing a case report. You can find valuable evidence and use it in your abstract, making it unique. 

  • Background: Should emphasise the importance of the chosen subject, as well-as the major factors that have influenced the case. In order to do so, we recommend having in mind the following: context, relevance and importance. 
  • Case description: History (describe briefly your patient’s medical history, to set-up a broader context and create an important link between a possible aetiology and the actual condition) and physical examination (acknowledge important details that can be revealing). 
  • Conclusion: This section allows you to summarise the topic and make an objective comparison with the updated specialty literature. Make sure this section reflects the significance of the clinical situation for medicine.  

KEYWORDS are mandatory, as they allow you to highlight the most important aspects of your abstract. They are a tool to help indexers and search engines find relevant papers. They should be representative but also specific for your paper. 

Abstracts of Case Reports should be consistent with the CARE guidelines and authors should send, if requested, the raw data file used for statistical and the complete list of references if applicable.

Review

A Review is a study focused on a clinical topic, based on a substantial search in the literature. The main and fundamental role of a review is to create a comprehensible blend of the best resources available about an important topic. The importance of review articles is increased due to the fact that clinicians benefit from them by updating their knowledge in their field of study.

If requested, the participant must provide the raw data file used for statistical analysis and the complete list of references if applicable.

  • Background: It stands as a hypothesis for your study. It is a brief description of what is known about the subject you chose and its significance for research. 
  • Materials and Methods: Relevant details about the study that were used for this paper, number of patients, basic characteristics (age group, gender etc.). Also mention why you chose these studies  and why are they relevant for your paper.. 
  • Results: Present the main outcome of your review in an attractive manner. Create a strong link between the original hypothesis and the final results, relating all of the ultimate data to it. Don’t try to include everything. Just provide a very brief summary of your main findings.  
  • Conclusion: This section allows you to summarise the topic and make a statement about the results you obtained. Your conclusion may be in line with your original hypothesis or not. Either way, you have to be very clear. 

KEYWORDS are mandatory, as they allow you to highlight the most important aspects of your abstract. They are a tool to help indexers and search engines find relevant papers. They should be representative but also specific for your paper. 

Abstracts of Reviews should be consistent with the PRISMA guidelines and authors should send, if requested, the raw data file used and the complete list of references if applicable.

All Abstracts must have…

Abstract title 

  • Should not be longer than 12 words;  
  • The language used should be simple;
  • We recommend making it captivating and intriguing, but also clearly stating your intention.

Authors 

  • Write the full name of each author;  
  • Institutional affiliation (name of the institution) MUST be displayed under the author’s name (name of department/institution, city, state); please check the proper name of the institution in English. 

The maximum number of words in an abstract is 350, without taking into consideration the following fields: Title, Author, Co-authors, Scientific Coordinators, Affiliation and Keywords.

Tips & Tricks

Your abstract should be written in such a manner that anyone who reads it understands the subject of your scientific paper. Here are some tips & tricks to make your work easier: 

  1. Aim for a title that’s easy to understand and that sparks curiosity. 
  2. First write briefly the main ideas for each part of the abstract – this way you shouldn’t forget any essential information. 
  3. Then, create your sentences but keep it simple! – steer clear of long sentences and useless words. They make your abstract hard to read and you’ll probably also exceed the word limit.  

DO: 

  • Use plurals, in order to avoid indefinite articles
  • Use few adjectives
  • Make sure to verify the whole information within the abstract at the end. 
  • Keep an eye on your word count. If you are running into any issues then start rephrasing your text (to have fewer words). Make sure not to lose any important ideas on the way. 
  • Only use standard abbreviations (it must be clear what you are referring to)

DON’T:

  • Use adjectives such as ‘very’, ‘extraordinary’, etc. They are not necessary and only limit your word count. The results should speak for themselves.
  • Repeat yourself
  • Forget to check your grammar and spelling

Oral Presentation

This year, there are two categories for the Oral Presentations: PowerPoint Presentations and Poster Presentations.  Both the PowerPoint and the Poster Presentations will have the following sections: Fundamental Sciences, Clinical Sciences and Surgical Sciences. This year, all Poster presentations will be organised as an e-poster competition, requiring participants to present their poster in a digital format. 

All Poster Presentations will be held exclusively on-site on Friday, the 6th of December 2024. The PowerPoint Presentations will be held exclusively on-site on Saturday, the 7th of December 2024. The exact schedule and location information will be shared with the participants before the 18th of November.  On-site Participants will be able to attend the presentation of the abstracts and they will also have the right to ask questions regarding the content of the presentations.

In advance, every participant that has been accepted for the Oral Presentations will have to send their visual support (.ppt/.pptx for the PowerPoint presentations or the electronic format of the Poster for the Poster Presentations) until the 25th of November 2024, 23:59 GMT+2 (Romanian time zone) at the e-mai: abstracts@imscbucharest.com.

During presentations’ day, the order in which the sections will be presented during the PowerPoint/Poster  Presentations  is the following:

  • Review
  • Original Study
  • Case Report

For each of the sections, the alphabetical order will be respected.

Presenters’ Duties:

  • The Presenters must be present 15 minutes before the start of the Oral Presentations competition.
  • The Presenters cannot leave the room before the end of the last presentation from their section (Review, Original Study, Case Report); in the event in which they can not respect this rule, they will be disqualified.
  • The Organising Committee of the IMSCB is not responsible if any of the conditions specified above is not met.

The official language of the Congress is English. This being given, the visual support (PowerPoint or Poster), the oral presentations and the short Q&A session for each participant will all be held in English. No other language is accepted.

As far as the visual support is concerned, please make sure you adhere to the rigours imposed here.

The presentation time for each participant will be 7 minutes for PowerPoint Presentations, and 5 minutes for Poster Presentations, followed by a 3-minute Q&A session (both the professors of the Scientific Committee and the other Presenters will be allowed to ask questions). You will be notified during the presentation when there are 3 minutes and respectively 1 minute left of the presentation time. Please note that exceeding the time limit will influence your final score!

Your speech should be clear and coherent. We kindly suggest that you speak freely, without using any supplementary support except the slides of the presentation. This is a simple manner to improve the Scientific Committee’s opinion on your public speaking abilities and to make an honest self-evaluation of your efforts. And do not forget: you are the best storyteller as far as the story of your research is concerned! Make the most of it!

Power Point Structure

Structure:

  • Please follow the given template;
  • The format accepted for the presentation is .ppt/.pptx;  
  • We recommend using a font of at least a 22 font size for the text; 
  • Do not fill your slides with blocks of text. We suggest you write exclusively the main ideas on the slides and tell the whole story behind them through your convincing speech; 
  • Remember the importance of diagrams, images and animations; 
  • All the tables and graphics must contain a title and a legend 

We recommend having the following structure for your visual support: 

  • The first slide should contain the following information: the title of the paper, the author’s name, the affiliation and the logos pertaining to the affiliation and to the congress. 
  • The next slide should consist of a table of contents. It is optional, but good to have. It helps your audience to better comprehend the presentation. 
  • In the succeeding 1-2 slides you should have an introduction. In this part, you should present the subject which you are going to speak about. 
  • After the introduction, there will be a number of 15 to 20 slides that should contain the main ideas of the paper organised in a brief manner (Materials and Methods + Results). 
  • Your conclusion should consist of 1-2 slides in which you should have a “take home” message for your audience. You should concentrate all your findings in a concise way. 
  • The last slide should contain all your references. 

Poster Structure

Please ensure that your poster fits the A0 measurement guidelines: 841 x 1189 mm. This year, all Poster presentations will be organised as an e-poster competition, requiring participants to present their poster in a digital format.

  • Please follow the measurements and format required  (A0; no pre-imposed template).
  • Do not overfill your poster with too much text. We recommend the 40-40-20 rule (40% blank space, 40% visuals, 20% text).
  • Ensure that the font you use is amongst the Sans Serif category.
  • Emphasise your ideas through relevant pictures, tables or graphics. Make sure they are accompanied by a title and legend. Try to go with no more than 2 colours as using more can become rather tiring to the eye. If you need help pairing colours, the colour wheel shall become your best friend.
  • Stay away from the red and green combination. 
  • Be coherent with your order. Make sure your poster is easy to follow and the viewer doesn’t have to jump from a place to another in order to understand.

Transmit Idea 

Congratulations on the acceptance of your abstract for an Oral Presentation, this being the final step in the research process. Each will be allotted seven (7) minutes for your presentation, in the case of PowerPoint Presentations, and five (5) minutes for Poster Presentations, followed by a period of three (3) minutes for the Q&A session. During oral presentations, the audience is very attentive and focused on the presenter, so we provide you a guide that will help you turn your hard work into a successful experience. 

  • Preparing
    • It is crucial to know your material inside out. Therefore, a MUST is improving your delivery skills, in order not to sound plain, but rather enthusiastic and passionate. 
    • Get a colleague or co-author to analyse your visual support and oral presentation beforehand. The refined end product is what the audience will see and hear, so you must pay attention to all the details. 
  • Giving the presentation
    • Exercise your speech in order to make it cursive.  Avoid stalling. 
    • Look at the camera while you deliver your speech, not at the slides (as one can tell the difference). 
    • Demonstrate enthusiasm and emotion, use gestures to emphasise certain ideas. 
    • Deliver a clear, important, take-home message from your work – one that would be valued unanimously. Make a firm closing. 
  • Answering questions
    • Listen to the question carefully – you can repeat a part of the question in the answer to make sure you understood correctly and that you will deliver the message properly. 

Fundamental Poster

CARving New Paths: Advancements and Challenges in CAR T-Cell Therapy for Lymphoid Malignancies

Daria Vreme

93,75

Can Social Marketing Have an Impactin Melanoma Prevention?

Beatrice-Corina Tataru

93,00

COMPARATIVE ANALYSIS OF THE HISTOMORPHOLOGICAL CARACTERISTICS OF FETAL AND ADULT CARDIAC MUSCLE

Ana-Marija Jokić

91,25

COMPARATIVE ANALYSIS OF HISTOMORPHOLOGICAL CARACTERISTICS OF FETAL AND ADULT SKIN

Filip Kapor

88,67

FREQUENCY OF CATALASE AND SUPEROXIDE DISMUTASE GENE VARIATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Anastasija Kostic

87,83

Beyond Stones: Treatment challenges of a lifelong condition, and exploring novel approaches

Bogdan Borzei

82,25

An unsual,rare, specifically located skin condition:Buschke-Fisher-Brauer Syndrome

Ruxandra Ioana Petreuș

81,58

Surgical Poster

Right Upper Quadrant Subcutaneous Fistula from Acute Cholecystitis

Maria Militaru

92,17

Uncommon and Aggressive Glial Tumor: Gliosarcoma – A Case Report

Cristiana-Teodora Isac

88,5

A RARE CASE OF SIGMOID COLON DUPLICATION

Micu Magda-Melisa

88

A better tool for a better view: SMILE vs FS-LASIK

Păun Maria-Andrada

88

Unpredicted emergency surgery after in vitro fertilization – case report and literature review

Ioana-Marta Melinte

87,83

Surgical Treatment for Gallbladder Cancer: A Case Report

Miruna Koşa

86,00

Deep infiltrating endometriosis: a rare cause of intestinal obstruction

Cristiana Guzu

85,67

Chemotherapy-related complications: managing botryomycosis in oncology

Nemtan-Nisioiu Ionela-Bianca

84

Hunter Procedure: A Wacky Journey Through Tendon Repair and other Skin Surprises!

Feraru Andreea-Ioana

82,83

The Dynamics ofBilateral Rapidly Progressive Osteoarthritis ofthe Hip: A Case Report

Dan Paul Ioan

81,33

Clinical Poster

Dysregulation of genes involved in the long-chain fatty acid transportin pancreatic ductal adenocarcinoma

Anastasia-Maria Dobre

93,17

A rare cause of upper lid swelling: Case Report

Galbau Stefan

92,67

Massive Hemorrhage: When Tumors and Vascular Malformations Meet - A Case Report

Dragoș Alexandru Gălățanu

91,33

When the kidneys fail so does the heart

Pastor Vlad

91,33

Obstacles Keep Coming: Managing Liver Cirrhosis with Refractory Ascites and Flood Syndrome

Bianca Andreea Radu

91,00

Identifying patients at risk for interstitial lung disease in systemic scleroderma

Miruna Antonia Ilea

89,17

Challenges of Prolonged Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome

Elisabeta Sasu

88,83

Beyond the Basics: Managing Bulbar Ischemic Stroke and Myasthenia Gravis in an Elderly Patient

Gârbacea Raul-Ioan

88,00

Idiopathic Retroperitoneal Fibrosis: a Case Report

Andrei-Daniel Dragne

86,67

A Hidden Threat: Late-Onset Obstructive Jaundice After Diagnosis of Duodenal Adenocarcinoma

Radu Sabău

86,67

A need for speed solution for a brake-free challenge

Carolina Nunu

85,83

Putting Life on Hold: A Case of Mixed Anxiety-Depressive Disorder during Adolescence

Vlad Răzniceanu

83,83

An ultrasound-based diagnosis of aorto-mesenteric clamp syndrome

Marta Ecaterina Beșleagă

83,67

Fundamental Oral Presentations

The neural fingerprint ofletters: decoding letters and fonts from EEG signals

Majercsik Szilárd-Attila

92,50

The incidence and variability ofthe persistent metopic suture in a population of crania from the inter-war population

Maria Voinea

91,33

MATRIX METALLOPROTEINASES: NONPROTEOLYTIC ACTIVATION AND ITS RELEVANCE IN MEDICINE

Teodor Cârloanță

85,33

FERROPTOSIS-INDUCED PULMONARY FIBROSIS: MECHANISTIC INSIGHTS AND THERAPEUTIC PROSPECTS

Cristina Trocin

85,17

Aluminum Chloride Topicals: New Golden Standard for Axillary Hyperhidrosis or a Leading Cause ofBreast Cancer?

Vlad-Craioveanu-Motomancea Mara-Atena

84,83

BRAIN GLYCOSYLATION AND PARKINSON’S DISEASE DEVELOPMENT - MECHANISMS AND PROSPECTS

Iustina ROȘU

84,50

The Optimistic Future of Alzheimer’s Treatment: Exploring Monoclonal Antibody Therapy Advances

Maria-Sarah Boșneagă

83,17

Treatment for paediatric Acute Lymphoblastic Leukaemia: a review on Blinatumomab

Gabriel-Erich Ganea

81,67

Artificial Blood: A Solution for Blood Transfusion Shortages

Nicolae-Florin Iftimie

81,50

Exploring DeepBrain Stimulation for Obsessive-Compulsive Disorder and Treatment-Resistant Depression

Ioana-Flavia Gheorghiu

81,17

Mind and Gut: New perspective into ghrelin functions

Botezatu Maria

81,00

MORPHOMETRIC AND QUANTITATIVE CHANGES OFBRONCHOASSOCIATED LYMPHOID TISSUE UNDER THE INFLUENCE OF SODIUM GLUTAMATE, SODIUM NITRATE AND PONCEAU 4R

Taras Demchencko

80,17

Tumor infiltrating lymphocytes’role in breast cancertreatment

Miruna Elena Stratone

80,17

Dysregulation of Ubiquitin-Proteasomal Pathway in Neurodegenerative Diseases: A Narrative Review

Sebastian-Marian Leonte

79,50

Breaking the Chain: Preventing Mother-to-Child Transmission of MPOX

Maria Dumitriu

78,50

Testicular Sertoli celltumor – a case report

Ștefan Chiru

76,33

CRISPR/Cas Systems – The Next Breakthrough in theBattle Against HIV

Felix-Marian Geodoiu

75,00

Recurrent angiomatoid fibrous histiocytoma with EWSR1 gene involvementin a young woman

Nagy Kristóf-Gergő

74,67

Stroke Rehabilitation: Strategies for Recovery, Empowerment and Regaining Independence

Cristina-Ştefania Iorga

74,50

Review of Immune Checkpoint Inhibition in Metastatic Colorectal Cancer: Advances and Challenges

Condurache Stefan Lucian

71,67

Clinical Oral Presentations

Approaches for handling aortic valve replacement complications

Miruna Harter-Radu

93,5

Comprehensive Morphometric Analysis and 3D Modeling of the Triangular Recess

Maria-Bianca Andrei

93,17

A Double-Edged Stream: Bilateral Vesicoureteral Reflux and Ureter Duplication in a Pediatric Case—A Battle Against Recurrent Infections and Chronic Kidney Decline

Alexia Urtoi

92,83

Investigation of Cryptogenic Stroke Among Patent Foramen Ovale patients at Sultan Qaboos University Hospital: A Case-Control study

Ahmed Al-Farsi

91

EYES ON HEMORRHAGIC SHOCK IN A PEDIATRIC PATIENT WITH DUODENAL ULCER

Velicu Elisa-Octavia

90,50

Exploring the Complexities of Dual Malignancies: Bronchopulmonary Neoplasm and Melanoma

Vrăjitoru Iuliana

90,5

The early bird catches the worm – a complicated case of Crohn’s Disease

Imbrea Mara-Lorena

83,67

Beyond the Thyroid – Uncovering Rare Overlap of Celiac Disease and Autoimmune Thyroiditis

Ioana Adumitresei

89,67

COVID-19: A trigger for Takayasu Arteritis

Ciornohuz Dinu

89,33

Takotsubo Syndrome: How Does Emotional Distress Translate Into Physical Cardiac Dysfunction?

Bianca-Cristina Chiperi

89,17

A genetic disease hidden behind limited manifestations

Matei Alexandru Costin

89,17

Urinary Lithiasis and Obesity: Monitoring lithiasic patients with obesity

Tănasă Ana Alexia

89,17

NAVIGATING THE CHALLENGES OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ADMINISTRATION IN CARDIAC PACIENT UNDER ANTICOAGULANT THERAPY

Satcău Ivona Elena

88,50

From Blindness to Recovery: A Case of Syphilitic Placoid Chorioretinitis

Karina Matei

87,50

MEANS FOR PREDECTING MORTALITY IN SEVERE, BACTERIAL SUPRAINFECTED INFLUENZA CASES

Alexandra Ripea

85,50

SGLT2 Inhibitors in Heart Failure Management – A Systematic Review

Mihnea Cozac

85,50

Analysis of severe COVID-19 cases in the Ukrainian population in 2020-2022

Taisiia Siemieniak

85,17

Steinert's myotonic dystrophy: progressive muscle weakness in a young adult

Alexandru Călin

84,17

The early bird catches the worm – a complicated case of Crohn’s Disease

Imbrea Mara-Lorena

83,67

Dual Symptom Management in Fibromyalgia: How TMS Reduces Both Pain and Depression

Daniel Buznean

83,50

Escherichia coli meningoencephalitis in newborns: a predictable diagnosis or medical challenge?

Mara-Georgiana Uliliuc

90,33

Imagistic evaluation of ventricular functions following a viral myocarditis

Benedek Bianka Krisztina

44,83

Surgical Oral Presentations

Acute management of aortoesophageal fistula:thoracic endovascular aortic repair and esophageal stenting

Alexandru-Sebastian Stoica

94,50

Breast Implant Associated Anaplastic Large Cell Lymphoma - Reality or Fiction? A Systematic Review

Radu Alexandru Ilieș

91,17

Complex Surgical Management of Thoracic Spine Trauma – High-Speed Bicycle Accident Aftermath

Velnic Cosmin-Ștefan

90,50

Uterine Torsion at Term – An Unpredictable and Perilous Event

Maria Pîrcălabu

89,33

Rooting Out Advanced Ovarian Cancer: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Approach

Alexia Gabriela Stratan

89,17

Modified T-configured dual stenttechnique for a complex basilartip aneurysm

Alexandra Rusu

89,00

Achilles tendon lengthening: Percutaneous versus Z-lengthening surgical approach

Cristea Erika Maria

88,83

Primary MeningealB-cell Lymphoma with Involvement ofthe Calvaria - A Rare Case

Plamen Penchev

88,17

Complex myocardial revascularization: a variant of the "π"-graft technique

Adrian-Emil Gavriluț

87,50

Exploring Retroperitoneal Liposarcomas: A Journey Through Diagnosis and Therapeutic Approaches

Ioana-Ecaterina Barnea

87,33

An incidental finding of a AVM in a pediatric patient with a subarachnoid hemorrhage

Vladislav Velchev

86,83

From Burn Scar to Skin Cancer: Surgical Management of Marjolin’s Ulcer

Alexandru-Ionuț Sănduleanu

86,67

Ultrasonographic assessment oflabial artery topography to minimize risks in injectionology

Filipoiu Zoran-Florin

86,33

Surgical Insights into Recurrent Foramen Magnum Meningioma: A Clinical Case

Matei-George Ilie

85,33

Robot assisted radical prostatectomy a 40 years old male patient case report

Vakalidis Ioannis

85,33

Endometriosis- from hidden pain to healty reproduction

Maria-Gabriela Munteanu

84,67

Surgical Management and Reconstruction of Lower Lip with Squamous Cell Carcinoma

Druhuș Daria Elena

84,00

Toothfairy may restore your sight? Osteo-odonto-keratoprosthesis a review of an unusual procedure

Bogdan-Tudor Bugeac

82,17